Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
beta amyloid
Research
Denali Alzheimer's antibody clears plaques without ARIA in mice
The Bay Area biotech plans to bring an optimized form of the antibody, which targets beta amyloid, into the clinic in 2026.
Darren Incorvaia
Aug 7, 2025 2:00pm
Eisai rocked by 2nd death ahead of Alzheimer’s data reveal
Nov 28, 2022 10:53am
In 'major surprise,' Eisai, Biogen post pivotal Alzheimer's win
Sep 28, 2022 4:30am
Scientists find druggable path that may help treat Alzheimer's
Aug 29, 2022 7:26pm
FDA clears its first early amyloid test for Alzheimer’s disease
May 10, 2022 11:42am
Biogen, Eisai move into PhIII with BACE inhibitor in Alzheimer’s
Aug 9, 2016 1:00pm
